Condition: Joint Diseases · Sponsor: MicroPort Orthopedics Inc.
MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® Revision Tibial System and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.
This description comes directly from the study's public registry record.
JoAnna-Marie N Becker, BS · +1 901 290 5280 · joannamarie.becker@ortho.microport.com
Pietro Randelli, Prof · +39-335-5292-622 · pietro.randelli@unimi.it
Always discuss trial participation with your own doctor first.
| Gaetano Pini Orthopedic Institute | Milan, Piazza C. Ferrari 1 20122 Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06142669